Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014 (2014), Article ID 587083, 8 pages
http://dx.doi.org/10.1155/2014/587083
Clinical Study

Xanthine Oxidase Activity Is Associated with Risk Factors for Cardiovascular Disease and Inflammatory and Oxidative Status Markers in Metabolic Syndrome: Effects of a Single Exercise Session

1Faculdade de Enfermagem, Nutrição e Fisioterapia, Pontifícia Universidade Católica do Rio Grande do Sul, Avenida Ipiranga 6681, Prédio 12, 8°andar, 90619-900 Porto Alegre, RS, Brazil
2Programa de Pós-Graduação em Medicina e Ciências da Saúde, Pontifícia Universidade Católica do Rio Grande do Sul, Avenida Ipiranga 6690, 90610-000 Porto Alegre, RS, Brazil
3Departamento de Farmacologia, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Rua Sarmento Leite 500, 90050-170 Porto Alegre, RS, Brazil

Received 22 November 2013; Revised 5 April 2014; Accepted 19 April 2014; Published 21 May 2014

Academic Editor: Neelam Khaper

Copyright © 2014 Ana Maria Pandolfo Feoli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. National Institutes of Health et al., ATP III Guidelines At-A-Glance Quick Desk Reference, NIH Publication, 2001.
  2. Atlas Diabetes, “International Diabetes Federation,” 2000, http://www.idf.org/diabetesatlas.
  3. S. Mottillo, K. B. Filion, J. Genest et al., “The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis,” Journal of the American College of Cardiology, vol. 56, no. 14, pp. 1113–1132, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. K. G. M. M. Alberti, R. H. Eckel, S. M. Grundy et al., “Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; And international association for the study of obesity,” Circulation, vol. 120, no. 16, pp. 1640–1645, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. X. Sui, T. S. Church, R. A. Meriwether, F. Lobelo, and S. N. Blair, “Uric acid and the development of metabolic syndrome in women and men,” Metabolism: Clinical and Experimental, vol. 57, no. 6, pp. 845–852, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Vávrová, J. Kodydková, M. Zeman et al., “Altered activities of antioxidant enzymes in patients with metabolic syndrome,” Obesity Facts, vol. 6, no. 1, pp. 39–47, 2013. View at Google Scholar
  7. M. Dobiasova, “AIP-atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice,” Vnitřní lékařnství, vol. 52, no. 1, pp. 64–71, 2006. View at Google Scholar
  8. C. A. J. Farquharson, R. Butler, A. Hill, J. J. F. Belch, and A. D. Struthers, “Allopurinol improves endothelial dysfunction in chronic heart failure,” Circulation, vol. 106, no. 2, pp. 221–226, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Mankovsky, R. Kurashvili, and S. Sadikot, “Is serum uric acid a risk factor for atherosclerotic cardiovascular disease?: a review of the clinical evidence. Part 1,” Diabetes and Metabolic Syndrome: Clinical Research and Reviews, vol. 4, no. 3, pp. 176–184, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Kanbay, M. Segal, B. Afsar, D. H. Kang, B. Rodriguez-Iturbe, and R. J. Johnson, “The role of uric acid in the pathogenesis of human cardiovascular disease,” Heart, vol. 99, no. 11, pp. 759–766, 2013. View at Google Scholar
  11. A. Brandão, A. A. Brandão, A. da Rocha Nogueira et al., “I Diretriz brasileira de diagnóstico e tratamento da síndrome metabólica,” Brasileiros de Cardiologia, vol. 84, supplement I, pp. 1–28, 2005. View at Google Scholar
  12. A. G. Ioachimescu, D. M. Brennan, B. M. Hoar, S. L. Hazen, and B. J. Hoogwerf, “Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a Preventive Cardiology Information System (PreCIS) database cohort study,” Arthritis and Rheumatism, vol. 58, no. 2, pp. 623–630, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Okamoto, B. T. Eger, T. Nishino, S. Kondo, E. F. Pai, and T. Nishino, “An extremely potent inhibitor of xanthine oxidoreductase: crystal structure of the enzyme-inhibitor complex and mechanism of inhibition,” The Journal of Biological Chemistry, vol. 278, no. 3, pp. 1848–1855, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Puddu, G. M. Puddu, E. Cravero, L. Vizioli, and A. Muscari, “The relationships among hyperuricemia, endothelial dysfunction, and cardiovascular diseases: molecular mechanisms and clinical implications,” Journal of Cardiology, vol. 59, no. 3, pp. 235–242, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Furukawa, T. Fujita, M. Shimabukuro et al., “Increased oxidative stress in obesity and its impact on metabolic syndrome,” Journal of Clinical Investigation, vol. 114, no. 12, pp. 1752–1761, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. V. O. Palmieri, I. Grattagliano, P. Portincasa, and G. Palasciano, “Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome,” The Journal of Nutrition, vol. 136, no. 12, pp. 3022–3026, 2006. View at Google Scholar · View at Scopus
  17. P. Galassetti, “Inflammation and oxidative stress in obesity, metabolic syndrome, and diabetes,” Experimental Diabetes Research, vol. 2012, Article ID 943706, 2012. View at Google Scholar
  18. S. Devaraj, U. Singh, and I. Jialal, “Human C-reactive protein and the metabolic syndrome,” Current Opinion in Lipidology, vol. 20, no. 3, pp. 182–189, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Vorbach, R. Harrison, and M. R. Capecchi, “Xanthine oxidoreductase is central to the evolution and function of the innate immune system,” Trends in Immunology, vol. 24, no. 9, pp. 512–517, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur, and J. Telser, “Free radicals and antioxidants in normal physiological functions and human disease,” International Journal of Biochemistry and Cell Biology, vol. 39, no. 1, pp. 44–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Isogawa, M. Yamakado, M. Yano, and T. Shiba, “Serum superoxide dismutase activity correlates with the components of metabolic syndrome or carotid artery intima-media thickness,” Diabetes Research and Clinical Practice, vol. 86, no. 3, pp. 213–218, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Google Scholar · View at Scopus
  23. N. Prajda and G. Weber, “Malignant transformation linked imbalance: decreased xanthine oxidase activity in hepatomas,” FEBS Letters, vol. 59, no. 2, pp. 245–249, 1975. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Wendel, “Glutathione peroxidase,” in Enzymatic Basis of Detoxification, W. B. Jakoby, Ed., vol. 1, pp. 333–353, Academic Press, New York, NY, USA, 1980. View at Google Scholar
  25. J. Buege, “Microsomal lipid peroxidation,” in Methods in Enzymology, S. Fleischer and L. Packer, Eds., pp. 302–310, Academic Press, New York, NY, USA, 52 edition, 1978. View at Google Scholar
  26. K. Yagi, “Simple assay for the level of total lipid peroxides in serum or plasma,” Methods in Molecular Biology, vol. 108, pp. 101–106, 1998. View at Google Scholar · View at Scopus
  27. F. Facchini, Y.-D. I. Chen, C. B. Hollenbeck, and G. M. Reaven, “Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration,” Journal of the American Medical Association, vol. 266, no. 21, pp. 3008–3011, 1991. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Pasalic, N. Marinkovic, and L. Feher-Turkovic, “Uric acid as one of the important factors in multifactorial disorders—facts and controversies,” Biochemia Medica, vol. 22, no. 1, pp. 63–75, 2012. View at Google Scholar · View at Scopus
  29. Y. Fujii, A. Okada, T. Yasui et al., “Effect of adiponectin on kidney crystal formation in metabolic syndrome model mice via inhibition of inflammation and apoptosis,” PloS ONE, vol. 8, no. 4, Article ID e61343, 2013. View at Google Scholar
  30. K. Stanhope, J. Schwarz, and P. Havel, “Adverse metabolic effects of dietary fructose: results from the recent epidemiological, clinical, and mechanistic studies,” Current Opinion in Lipidology, vol. 24, no. 3, pp. 198–206, 2013. View at Google Scholar
  31. G. Baskol, M. Baskol, and D. Kocer, “Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis,” Clinical Biochemistry, vol. 40, no. 11, pp. 776–780, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. H. L. Kin, L. C. Yu, B. C. Wing, J. C. N. Chan, and C. W. W. Chu, “Mesenteric fat thickness is an independent determinant of metabolic syndrome and identifies subjects with increased carotid intima-media thickness,” Diabetes Care, vol. 29, no. 2, pp. 379–384, 2006. View at Google Scholar · View at Scopus
  33. B. Gustafson, A. Hammarstedt, C. X. Andersson, and U. Smith, “Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 11, pp. 2276–2283, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Gustafson, “Adipose tissue, inflammation and atherosclerosis,” Journal of Atherosclerosis and Thrombosis, vol. 17, no. 4, pp. 332–341, 2010. View at Google Scholar · View at Scopus
  35. N. Villanova, S. Moscatiello, S. Ramilli et al., “Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease,” Hepatology, vol. 42, no. 2, pp. 473–480, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Yokota, S. Kinugawa, M. Yamato et al., “Systemic oxidative stress is associated with lower aerobic capacity and impaired skeletal muscle energy metabolism in patients with metabolic syndrome,” Diabetes Care, vol. 36, no. 5, pp. 1341–1346, 2013. View at Google Scholar
  37. S. Chen, C. H. Yen, Y. C. Huang, B. J. Lee, S. Hsia, and P. T. Lin, “Relationships between inflammation, adiponectin, and oxidative stress in metabolic syndrome,” PLoS ONE, vol. 7, no. 9, Article ID e45693, 2012. View at Google Scholar
  38. P. L. Huang, “eNOS, metabolic syndrome and cardiovascular disease,” Trends in Endocrinology and Metabolism, vol. 20, no. 6, pp. 295–302, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Jourd'heuil, F. L. Jourd'heuil, P. S. Kutchukian, R. A. Musah, D. A. Wink, and M. B. Grisham, “Reaction of superoxide and nitric oxide with peroxynitrite. Implications for peroxynitrite-mediated oxidation reactions in vivo,” The Journal of Biological Chemistry, vol. 276, no. 31, pp. 28799–28805, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Martinez-Hervas, J. T. Real, C. Ivorra et al., “Increased plasma xanthine oxidase activity is related to nuclear factor kappa beta activation and inflammatory markers in familial combined hyperlipidemia,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 20, no. 10, pp. 734–739, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Venojärvi, A. Korkmaz, N. Wasenius et al., “12 Weeks' aerobic and resistance training without dietary intervention did not influence oxidative stress but aerobic training decreased atherogenic index in middle-aged men with impaired glucose regulation,” Food and Chemical Toxicology, vol. 61, pp. 127–135, 2013. View at Google Scholar
  42. L. A. Gordon, E. Y. Morrison, D. A. McGrowder et al., “Effect of exercise therapy on lipid profile and oxidative stress indicators in patients with type 2 diabetes,” BMC Complementary and Alternative Medicine, vol. 8, article 21, pp. 1–10, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. G. Lazarevic, S. Antic, T. Cvetkovic, V. Djordjevic, P. Vlahovic, and V. Stefanovic, “Effects of regular exercise on cardiovascular risk factors profile and oxidative stress in obese type 2 diabetic patients in regard to SCORE risk,” Acta Cardiologica, vol. 63, no. 4, pp. 485–491, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Pereira, R. A. Tibana, J. Navalta et al., “Acute effects of resistance training on cytokines and osteoprotegerin in women with metabolic syndrome,” Clinical Physiology and Functional Imaging, vol. 33, no. 2, pp. 122–130, 2012. View at Google Scholar
  45. N. Greene, S. Martin, and S. Crouse, “Acute exercise and training alter blood lipid and lipoprotein profiles differently in overweight and obese men and women,” Obesity, vol. 20, no. 8, pp. 1618–1627, 2012. View at Google Scholar